Walter J. Koroshetz, M.D. - Chairperson
Dr. Koroshetz became Director of NINDS in June 2015. NINDS funds both research on basic neuroscience and studies of hundreds of neurological disorders. As Director, Dr. Koroshetz oversees an annual budget of $1.6 billion and a staff of more than 900 scientists, physicians-scientists, administrators.
Amy Brin, MSN, MA, PCNS-BC (2025)
Amy Brin is the the CEO of Amy Brin Consulting where she specializes in providing executive coaching, board development & training, change management, organizational assessment, and strategic planning services to individuals and organizations. Prior to that, she was the Executive Director and CEO of the Child Neurology Foundation (CNF), where she is furthering her commitment to the pediatric neurology community. She has established CNF as a convening patient advocacy organization across 300 disease states, driving impactful patient education and support programming. Prior to becoming CEO of CNF, Ms. Brin served as an Advance Practice Nurse with BlueGrass Care Navigators. She is also the lead pediatric provider for community and tertiary care programs while also directing daily clinical operations. Ms. Brin has experience with strategic planning and crisis management and has participated in grant reviews with the U.S. Department of Health and Human Services Genetic Services Branch. She is Board-certified in Pediatrics as a Clinical Nurse Specialist and is Chair of the Epilepsy Leadership Council. She earned a Master of Science degree in Nursing from Vanderbilt University in 2007.
Robert Brown, Jr., D.Phil., M.D. (2025)
Dr. Robert Brown is the Director of the University of Massachusetts Medical School Program for Neurotherapeutics. From 2008-2018, Dr. Brown served as Professor and Chair of Neurology at the University of Massachusetts School of Medicine. His clinical interests include amyotrophic lateral sclerosis (ALS), muscular dystrophy, and neurodegenerative disorders. Dr. Brown served as Co-Chair of the Board of Scientific Counsellors at the National Institute of Neurological Disorders and Stroke from 2018-2020. Dr. Brown has published numerous research articles, books, and reviews and received many honors throughout a career spanning over 40 years. Dr. Brown earned his M.D. from Harvard Medical School in 1975.
Stuart Hoffman, Ph.D. - Ex Officio Member
Dr. Stuart Hoffman is the Senior Health Science Officer for TBI for the Office of Research and Development (ORD), Veterans Health Administration, Department of Veteran Affairs (VA). He is responsible for supporting the National Research Action Plan activities; serving as VA Lead for the joint VA/Department of Defense Long-term Impact of Military-relevant Brain Injury Consortium (LIMBIC); providing overall direction, program planning, development and implementation for ORD TBI research; coordinating with ORD leads and Federal partners in other high priority nationwide efforts in brain health; promoting data sharing in TBI research; and to expand the clinical trials network nationally to improve TBI treatments and diagnostics for Veterans.
Dr. Hoffman joined the Rehabilitation Research and Development Service in ORD in February of 2010 where he served as the Scientific Program Manager for Brain Health and Injury. His accomplishments included doubling the RRD TBI portfolio, creating a special emphasis area for proposals investigating the long-term effects of prescribed and nonprescribed drugs on outcome from TBI, and oversight of two successful research centers. Dr. Hoffman received his Ph.D. in behavioral and molecular neuroscience at Rutgers University in 1995 and completed his postdoctoral training in pharmacology at Virginia Commonwealth University in 1997. Dr. Hoffman was a full-time Emory University faculty member from 1998-2006. Immediately prior to joining the VA in 2010. Dr. Hoffman was the Research Director for the Defense and Veterans Brain Injury Center in Johnstown, Pennsylvania. He has over 50 peer-reviewed publications and more than 35 years of translational neuroscience research experience that focused on TBI therapeutics.
Yishi Jin, Ph.D. (2026)
Dr. Yishi Jin is a Distinguished Professor and the Co-Director for the Kavli Institute of Brain and Mind at University of California San Diego. In her previous role at the University of California San Diego, she was a Professor in the Division of Biological Sciences. Dr. Jin’s laboratory focuses on neural development and regeneration in nematodes and studies the communication of neurons, formation of synapses, role of neural circuitry in controlling movement and regeneration of axons. Dr. Jin is a member of the Society of Neuroscience and Genetics Society of America and has contributed to many s scholarly publications throughout her career. Dr. Jin completed a Ph.D. in Molecular Biology at the University of California Berkeley in 1991.
Jane Larkindale, D.Phil. (2026)
Dr. Jane Larkindale is the Vice President of Clinical Science at PepGen Inc. Prior to PepGen, Dr. Larkindale worked as the Executive Director for Rare Disease Cures Accelerator- Data and Analytics Platform at the Critical Path Institute. Dr. Larkindale has expertise across rare diseases including neuromuscular diseases such as Duchenne and Myotonic muscular dystrophy, and Friedreich’s ataxia. She is a member of FARA Scientific Advisory Board and a member of Australasian Friedreich’s Ataxia Gene Therapy Consortium. Dr. Larkindale completed her D. Phil. in 2001 in the Department of Plant Sciences at Oxford University and is a Rhodes Scholar.
Jin-Moo Lee, M.D., Ph.D. (2026)
Dr. Jin-Moo Lee is the Andrew B. & Gretchen P. Jones Professor at Washington University School of Medicine in St. Louis, Missouri and the Chair of the Department of Neurology and Neurologist in Chief at Barnes-Jewish Hospital. Prior to becoming Chair, Dr. Lee served as the Co-Chair for the Stroke Care Clinical Program at BJC Healthcare in Missouri. Dr. Lee’s research focuses on pathophysiology and cellular/molecular mechanisms involved in brain injury following acute ischemia and chronic neurodegeneration. Dr. Lee has contributed to many articles and peer-reviewed publications. He earned an M.D. and Ph.D. in Neuroscience at Weill Cornell Medical College in 1993 and is the recipient of a Jacob Javits Investigator Award.
John Maunsell, Ph.D. (2025)
Dr. John Maunsell is the Albert D. Lasker Professor of Neurobiology and Director of the Grossman Institute for Neuroscience at the University of Chicago. Dr. Maunsell previously worked as a Professor in the Department of Neurobiology at Harvard Medical School. His research and scholarly interest areas include attention, vision, cerebral cortex, computation and optogenetics. Dr. Maunsell has published numerous research articles in the Journal of Neuroscience, Nature, and Visual Neuroscience throughout his career. He has received many awards, including grant funding from the NIH since the late 1980s. Dr. Maunsell is also a member of the American Association for the Advancement of Science Society for Neuroscience. He earned his Ph.D. in Biology at the California Institute of Technology in 1982.
Louise McCullough, Ph.D. (2025)
Dr. Louise McCullough is Professor and Chair of the Department of Neurology at the University of Texas Health Sciences Center McGovern Medical School. She is also Chief of the Neurology Service at Memorial Hermann Hospital, Texas Medical Center. Previously, Dr. McCullough was Professor and Director of Stroke Research and Education at the University of Connecticut Health Center. Dr. McCullough is a world leader in the area of cerebral vascular disease and was the recipient of an NINDS Javits Neuroscience Investigator Award. She currently serves as a member of the American Heart Association Science Advisory and Coordinating Committee as well as the Northeast Cerebrovascular Consortium. Dr. McCullough has authored or co-authored over 200 papers, received many honors and awards, and given numerous presentations both nationally and internationally. Dr. McCullough received her Ph.D. in Neuroscience from the University of Connecticut in 1992 and her M.D. from the University of Connecticut School of Medicine in 1996.
Henry L. Paulson, M.D., Ph.D. (2026)
Dr. Henry Paulson is the Lucile Groff Professor of Neurology at the University of Michigan and was a Research Professor at the Molecular and Behavioral Neuroscience Institute. Dr. Paulson’s interests concern the causes and treatments of age-related neurogenerative diseases, with an emphasis on polyglutamine disease, Alzheimer’s Disease, and frontotemporal dementia. Dr. Paulson is a NINDS Landis Outstanding Mentor Award recipient as well as an elected member of the National Academy of Medicine. He earned an M.D. and a Ph.D. (in Cell Biology) from the Yale University School of Medicine.
Terry Rauch, Ph.D. - Ex Officio Member
Dr. Terry Rauch is the Director of Medical Research and Development (R&D) at the U.S. Department of Defense (DoD) where he is responsible for strategic planning, analysis and oversight of the Defense Health Program R&D portfolio that includes combat trauma, infectious diseases, neurosciences, rehabilitation, and military social-behavioral dimensions. Dr. Rauch has over 40 years of experience in many facets of the Military Health System and has held numerous senior level positions in the Army and the Office of the Secretary of Defense. Dr. Rauch received a Bachelor of Science degree in psychology from the University of Cincinnati, where he also earned his Ph.D. in biology and psychology. Dr. Rauch has served as an expert medical witness for the U.S. Department of Justice as well as private industry on anthrax vaccine safety and efficacy and authored numerous scientific and technical publications in the field of psychology, neurosciences, and national security matters.